Tobacco Documents Online

88 Whyatt RM et at. CYPIA1 messenger RNA levels in placental tissue as a biomarker of environmental exposure. Cancer Eptdemiol Biomarkers Prey 1995; 4: 147-153. 89 Rammer H. Passively inhaled tobacco smoke: a challenge to toxicology and preventive medicine. Arch Toxicol 1987; 61: 89-104. 90 Langness U. Hydroxyproliuausscheidung und KollagenstoffwechseL Dtsch Mad Wochenschr 1970; 50: 2530-2535, 91 Kasuga H. An introduction to the study of smoking using urinary hydroxyproline, in Kasuga H [ed]: Indoor Air Quality. Berlin, Springer- Verlag, 1990: pp.37-52. 92 Adlkofer F, Scherer G, Holler W-D. Hydroxyproline excretion in urine of smokers and passive smokers. Prey Mad 1984; 13: 670-679. 93 Varplanke AJW et el. Hydr~xyproline excretion in schoolchildren and its relationship to measures of indoor air pollution. Int Arch Occup Environ Health 1987; 59: 221-231. 94 Adgate ]Let el. Nitrogen dioxide exposure and urinary excretion of hydroxyproline and desmosine. Arch Environ Health 1992; 47: 376- 3a4. 98 US Department of Health and Human Services. The Health Consequences of Smoking: Cardiovascular Disease: A Report of the Surgeon General. Rockville, Maryland, Public Health Service, 1983. 96 Glantz SA, Parmley WW. Passive smoking and heart disease. JAMA 1995; 273: 1047-1053. 97 Taylor A.E, Johnson DC, Kazeml H. Environmental tobacco smoke and cardiovascular disease. A position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association. Circulation 1992; 86: 699- 702. 98 Smith CJ et aL Urinary thromboxane and prostacyclin are not altered in nonsmokers living - with smokers. Blood 1997, submitted. 99 Sinzinger H, Kefalides A. Passive smoking severely decreases platelet sensitivity to antiaggregatory prostaglandins. Lancet 1982; 2: 392. 100 Burghuber OC et el. PlateIet sensitivity to prostacyclin in smokers and non-smokers. Chest 1986; 89: 34-38. 101 Sinzinger H, Virgolini I: Besitzen Passivraucher ein erh6htes Thromboserisiko? Wien Klin Wochenschr 1989; 101: 694-698. 102 Davis [W, Shelton L, Watanabe IS, Arnold J. Passive smok]ng affects endothelium and platelets. Arch Intern Mad 1989; 149: 386--389. 103 Howard Get aL Active and passive smoking are associated with increased carotid wall thickness. Arch Intern Mad 1994; 154: 1277-1282. 104 Diez-Roux AV at el. The relationship of active and passive smoking to carotid atherosclerosis 12-14 years later. Prey Med 1995; 24: 48-55, BIomonRorin= of ET~ ex!oo=ure G Soberer and E Richter 105 leo H et el. Passive smoking and plasma fibrinogen concentrations. Am ] EpidemioI 1996; 144: 1151-1154. 106 Kawachi I, Colditz GA. Invited commentary: Confounding, measurement error, and publication bias in studies of passive smoking. Am f Epidemiol 1998; 144: 909--915. 107 Feldman Jet el, Passive smokin8 alters lipid profiles in adolescents. Pediatrics 1991; 88: 259- 264. 108 Matanoski G, Kanchanaraksa S, Lantry D, Chang Y. Characteristics of nonsmoking women in NHANES I and NHAh-ES 1 epidemiologic follow- up study with exposure to spouses who smoke. Am ] Epidemiol 1995; 142: 149-157. 109 Svendsen KH, Kuller LJ, Martin MJ, Ockene Effects of passive smoking in the multiple risk factor intervention trial. Am ~ Epidemiol 1987; 126: 783- 795. 110 Szadkowski D, Harke HP, Angerar Kohlenmcnoxydbelastung dutch Passivrauchen in Bfirort/umen. Inn bled 1976; 3: 310-313. 111 Friedman GD, Petitti DB, Bawol R.D. Prevalence and correlates of passive smoking. Am .r Publ Health 1983; 73: 401-405. I12 Jarvis M et el. Biochemical markers of smoke absorption and self reported exposure to passive smoking. ] Epidemiol Commun Health 1984; 38: 335-33g. 113 Tunstal]-Pedoe H, Woodward M, Brown CA. Tea drinking, passive smoking, smoking deception and serum cotinine in the Scottish Heart Health Study..r Clin Epidemiol 1991; 44: 1411-1414. 114 Soberer G, Conze C, Angerer ~', Adlkefer F. Non- occupational exposure to benzene, in Mohr U (ed): Advances in Controlled Clinical Inhalation Studies. Berlin, Heidelberg, Springer-Ver]ag, 1993: pp. 387-392. 115 Wallace LA et el. Exposures to benzene and other volatile compounds from active and passive smoking. Arch Environ Health 1987; 42: 272- 279. 116 Buratti M st el. Evaluation of urinary t,t-muconic acid as a biomarker of benzene exposure related to ETS, in Maroni M fed): healty buildings '95 an international conference on healthy buildings in mild climate. Milano, healthy buildings '95, 1995: col 2, pp. 605 - 609. 117 Maclure M et el. Elevated blood levels of carcinogens in passive smokers. Am ~ Publ Health 1989; 79: 1381-1384. 118 Celermajer DS et el. Passive smoking and impaired endo~elinm-dependent arterial dilatation in healthy young adults. New Engl Med 1996; 334: 150--154. 119 Moskowitz WB et al, Lipoprotein and oxygen transport alterations in passive smoking preadolescent children. The MCV Twin Study. Circulation 1990; 81: 586--592. 459 This article is for individual use only and may not be further reproduced or stored electronically without written permission from the copyright holder. Unauthorized reproduction may result in financial and other penalties. (c) STOCKTON PRESS ENGLAND